British American Tobacco Isn't Cheap Enough To Justify The Risk

British American Tobacco remains a 'hold' as deteriorating fundamentals and limited upside outweigh growth in modern oral products. BTI's New Categories, particularly Velo and Vuse, are delivering strong market share gains, but core combustibles face long-term decline. Despite revenue growth, net income and EBITDA declined; cost-cutting and share buybacks are central to management's strategy. Valuation is not compelling—BTI trades above value ranges preferred for a bullish stance, with further downside risk if performance worsens.

Looking for a helping hand in the market? Members of Crude Value Insights get exclusive ideas and guidance to navigate any climate. Learn More »

Back in May of this year, I made the decision to downgrade shares of British American Tobacco (BTI)(BTIFF) from a ‘buy’ to a ‘hold’. I did not make this decision lightly. After all, the company certainly has